SCM
GH icon

Steadfast Capital Management’s Guardant Health GH Stock Holding History

Steadfast Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-87,150
Closed -$5.45M – 149
2025
Q3 		$5.45M Buy
+87,150
New +$4.74M 0.1% 81
2022
Q3 		– Sell
-465,839
Closed -$18.8M – 42
2022
Q2 		$18.8M Sell
465,839
-548,691
-54% -$27.2M 0.41% 33
2022
Q1 		$67.2M Buy
1,014,530
+5,499
+0.5% +$376K 1.15% 26
2021
Q4 		$101M Buy
+1,009,031
New +$104M 1.68% 23

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steadfast Capital Management's GH Position: Q4 2025 in Review

Steadfast Capital Management sold out of Guardant Health (GH) in Q4 2025, closing a stake of 87,150 shares — an estimated $5.45M sold.

Steadfast Capital Management first reported a position in GH in Q4 2021 and held it in 4 quarters. The position peaked at $101M in Q4 2021. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Steadfast Capital Management reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Steadfast Capital Management sold 87,150 Guardant Health shares in Q4 2025, an estimated $5.45M.
  • Steadfast Capital Management first reported a position in Guardant Health in Q4 2021 and held it in 4 quarters.
  • Steadfast Capital Management's Guardant Health position peaked at $101M in Q4 2021.
  • 497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Steadfast Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.